van de Kar NCAJ - Search Results

1

Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective.

Ter Avest M, Bouwmeester RN, Duineveld C, Wijnsma KL, Volokhina EB, van den Heuvel LPWJ, Burger DM, Wetzels JFM, van de Kar NCAJ, Ter Heine R; CUREiHUS study group. Ter Avest M, et al. Among authors: van de kar ncaj, van den heuvel lpwj. Nephrol Dial Transplant. 2023 Feb 13;38(2):362-371. doi: 10.1093/ndt/gfac056. Nephrol Dial Transplant. 2023. PMID: 35238929 Free PMC article.

2

Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.

Dorresteijn EM, van de Kar NC, Cransberg K. Dorresteijn EM, et al. Pediatr Nephrol. 2012 Jul;27(7):1193-5. doi: 10.1007/s00467-012-2130-z. Epub 2012 Mar 8. Pediatr Nephrol. 2012. PMID: 22399074 Free PMC article.

3

Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.

Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC. Geerdink LM, et al. Pediatr Nephrol. 2012 Aug;27(8):1283-91. doi: 10.1007/s00467-012-2131-y. Epub 2012 Mar 13. Pediatr Nephrol. 2012. PMID: 22410797 Free PMC article.

4

Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene.

Westra D, Vernon KA, Volokhina EB, Pickering MC, van de Kar NC, van den Heuvel LP. Westra D, et al. J Hum Genet. 2012 Jul;57(7):459-64. doi: 10.1038/jhg.2012.57. Epub 2012 May 24. J Hum Genet. 2012. PMID: 22622361 Free PMC article.

5

The challenge of managing hemophilia A and STEC-induced hemolytic uremic syndrome.

Westra D, Dorresteijn EM, Beishuizen A, van den Heuvel LP, Brons PP, van de Kar NC. Westra D, et al. Pediatr Nephrol. 2013 Feb;28(2):349-52. doi: 10.1007/s00467-012-2312-8. Epub 2012 Sep 23. Pediatr Nephrol. 2013. PMID: 23001024

6

Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.

Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.

7

Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome.

Wetzels JF, van de Kar NC. Wetzels JF, et al. Am J Kidney Dis. 2015 Feb;65(2):342. doi: 10.1053/j.ajkd.2014.04.039. Am J Kidney Dis. 2015. PMID: 25616634 No abstract available.

8

Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.

Volokhina EB, van de Kar NC, Bergseth G, van der Velden TJ, Westra D, Wetzels JF, van den Heuvel LP, Mollnes TE. Volokhina EB, et al. Clin Immunol. 2015 Oct;160(2):237-43. doi: 10.1016/j.clim.2015.05.018. Epub 2015 Jun 23. Clin Immunol. 2015. PMID: 26111482 Free article.

9

Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo.

Volokhina EB, Bergseth G, van de Kar NC, van den Heuvel LP, Mollnes TE. Volokhina EB, et al. Blood. 2015 Jul 9;126(2):278-9. doi: 10.1182/blood-2015-03-637645. Blood. 2015. PMID: 26160188 Free PMC article. No abstract available.

10

A young girl with an unusual cause of acute kidney injury: Questions.

Binkhorst M, Wijnsma KL, Steenbergen EJ, van de Kar NC, Schreuder MF. Binkhorst M, et al. Pediatr Nephrol. 2016 Nov;31(11):2071-3. doi: 10.1007/s00467-015-3170-y. Epub 2015 Aug 20. Pediatr Nephrol. 2016. PMID: 26289291 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page